Iterum Therapeutics PLC expected to post a loss of 4  cents a share - Earnings Preview

Iterum Therapeutics

25/03/2022 13:59

* Iterum Therapeutics PLC  ITRM.OQ   ITRM.O  is expected
to show
no change in quarterly revenue when it reports  results on March
28. 
    * ​Refinitiv's mean analyst estimate for Iterum Therapeutics
PLC
is for a loss of 4 cents per share. For the same quarter last
year, the company reported a loss of 27 cents per share.
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated March 25 at 13:59 GMT.  All
figures in US dollars  unless otherwise stated